Does TRABECTEDIN Cause Interstitial lung disease? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Interstitial lung disease have been filed in association with TRABECTEDIN (YONDELIS). This represents 1.2% of all adverse event reports for TRABECTEDIN.
24
Reports of Interstitial lung disease with TRABECTEDIN
1.2%
of all TRABECTEDIN reports
2
Deaths
16
Hospitalizations
How Dangerous Is Interstitial lung disease From TRABECTEDIN?
Of the 24 reports, 2 (8.3%) resulted in death, 16 (66.7%) required hospitalization, and 2 (8.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRABECTEDIN. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does TRABECTEDIN Cause?
Neutropenia (207)
Anaemia (189)
Thrombocytopenia (172)
Nausea (160)
Febrile neutropenia (142)
Pancytopenia (124)
Vomiting (121)
Rhabdomyolysis (117)
Off label use (105)
Alanine aminotransferase increased (104)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TRABECTEDIN Alternatives Have Lower Interstitial lung disease Risk?
TRABECTEDIN vs TRACLEER
TRABECTEDIN vs TRADJENTA
TRABECTEDIN vs TRALOKINUMAB-LDRM
TRABECTEDIN vs TRAMADOL
TRABECTEDIN vs TRAMADOL\TRAMADOL